EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacogenetic study of Asn680Ser and -29A>G in FSHR gene in Chinese women undergoing controlled ovarian hyperstimulation

Xiaohe Sun, Tianxiang Ni, Guangyu Li, Jingjing Jiang, Junhao Yan, Zi-Jiang Chen

Journal of Bio-X Research · 2018

DOI: 10.1097/jbr.0000000000000018 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bio-X Research, 2018. Verfasst von Xiaohe Sun und 5 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The outcome of controlled ovarian hyperstimulation (COH) is various and unpredictable. According to previous studies, 2 single nucleotide polymorphisms, Asn680Ser and -29A/G, have a pharmacogenetic association with ovarian response to COH. However, studies on the Asn680Ser polymorphism have yielded inconsistent conclusions and only a few studies with small sample sizes have been performed on -29A/G. The association of these 2 polymorphisms with ovarian response remains unclear. The present study evaluated the association of Asn680Ser and -29A/G genotypes with COH. A total of 414 Chinese women undergoing in vitro fertilization-embryo transfer were included. Genotypes for these single nucleotide polymorphisms were identified by high-resolution melting-curve analysis. The value of exogenous follicle-stimulating hormone dosage per oocyte divided by the body surface area (Dosage/Oocyte × Surface) was calculated for each patient as an indicator of ovarian response. The results of statistical analyses showed no association between Asn680Ser genotype and ovarian response. As for -29A/G, heterozygote individuals had more oocytes retrieved (P = 0.034). Combinatorial analysis of these 2 single nucleotide polymorphisms showed that genotype A/G-Asn/Asn had lower basal-follicle-stimulating hormone and more oocytes retrieved. Analysis of genotype association with ovarian response also revealed this genotype had a significantly higher risk of developing hyper response (OR = 7.86; 95% CI: 1.31–9.43). To some extent, there were associations between the studied polymorphisms and ovarian response; however, the power of this link is weak and has limited value for clinical prediction.

Zitieren

APA

Sun, X., Ni, T., Li, G., Jiang, J., Yan, J., & Chen, Z. (2018). Pharmacogenetic study of Asn680Ser and -29A>G in FSHR gene in Chinese women undergoing controlled ovarian hyperstimulation. Journal of Bio-X Research. https://doi.org/10.1097/jbr.0000000000000018

Vancouver

Sun X, Ni T, Li G, Jiang J, Yan J, Chen Z. Pharmacogenetic study of Asn680Ser and -29A>G in FSHR gene in Chinese women undergoing controlled ovarian hyperstimulation. Journal of Bio-X Research. 2018. doi:10.1097/jbr.0000000000000018

BibTeX
@article{Sun2018,
  author = {Sun, Xiaohe and Ni, Tianxiang and Li, Guangyu and Jiang, Jingjing and Yan, Junhao and Chen, Zi-Jiang},
  title = {Pharmacogenetic study of Asn680Ser and -29A>G in FSHR gene in Chinese women undergoing controlled ovarian hyperstimulation},
  journal = {Journal of Bio-X Research},
  year = {2018},
  doi = {10.1097/jbr.0000000000000018}
}
Kostenlos starten →